CellAegis Devices Announces US $9.5 Million Financing to Support Clinical and Regulatory Advancement of its autoRIC® Device
March 14, 2017
CellAegis Announces First Patients Enrolled in U.S. SHIELD Pivotal Clinical Trial
April 10, 2018

CellAegis Devices – Booth 1342
McCormick Place Convention Center
Chicago, IL. USA

The AHA Scientific Sessions 2018, starting from November 10–12 in Chicago, will provide a new dimension of cardiovascular research and clinical practice for Stroke Clinicians, Cardio professionals and many other cardio researchers.

Visit our booth to learn more about the advancements of the autoRIC® Therapy and how it can improve clinical outcomes by reducing Ischemic Injury to all key organs.

Get autoRIC®